Overview - Xiamen Kingdomway Group Co., Ltd. is issuing convertible bonds totaling RMB 1,292.39 million (12,923,948 bonds) [4][19] - The bonds will be listed on the Shenzhen Stock Exchange on September 8, 2025 [4][8] - The bonds have a maturity period from August 20, 2025, to August 19, 2031 [4][19] Company Information - The company was established on November 24, 1997, and is primarily engaged in the research, production, and sales of nutritional health foods and feed additives [11][12] - The registered capital of the company is RMB 609.93 million [9] - The company operates under the stock code 002626 and is listed on the Shenzhen Stock Exchange since October 28, 2011 [9][10] Business Operations - The main products include Coenzyme Q10, DHA, ARA, and various vitamins, with Coenzyme Q10 being the primary raw material [11] - The company has two major brands in the health food sector: Doctor's Best and Zipfizz [11] - The production model includes both self-production and contract manufacturing, with a focus on meeting customer demand [12] Financial Information - The total amount of the convertible bonds issued is RMB 1,292.39 million, with each bond having a face value of RMB 100 [19][20] - The interest rates for the bonds will increase progressively from 0.10% in the first year to 2.00% in the sixth year [20] - The net proceeds from the bond issuance will be used for various projects, including the construction of production facilities for Coenzyme Q10 and other operational needs [19][20] Shareholding Structure - The controlling shareholder is Xiamen Kingdomway Investment Co., Ltd., holding 34.71% of the company's shares [14][15] - The top ten shareholders include both domestic and foreign entities, with significant stakes held by state-owned enterprises [14][15] Credit Rating - The bonds have been rated AA by Dongfang Jincheng International Credit Rating Co., Ltd., with a stable outlook [6][20] - The bonds are not secured by any collateral [6][20]
金达威: 向不特定对象发行可转换公司债券上市公告书